XML 61 R36.htm IDEA: XBRL DOCUMENT v3.25.0.1
REVENUES (Tables)
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue The Company’s revenue by segment payers/customer groups is as follows:
Year Ended December 31, 2024Year Ended December 31, 2023Year Ended December 31, 2022
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Payer/Customer
Dx
   Clients24 %— %— %24 %24 %— %— %24 %22 %— %— %22 %
   Patients10 %— %— %10 %%— %— %%%— %— %%
   Medicare and Medicaid%— %— %%%— %— %%%— %— %%
   Third party36 %— %— %36 %36 %— %— %36 %39 %— %— %39 %
Total Dx revenues by payer78 %— %— %78 %77 %— %— %77 %77 %— %— %77 %
BLS
   Pharmaceutical, biotechnology and medical device companies%%%22 %10 %%%23 %10 %%%23 %
Total revenues87 %%%100 %87 %%%100 %87 %%%100 %
Contract with Customer, Contract Asset, Contract Liability, and Receivable
The following table provides information about accounts receivable, unbilled services, and unearned revenue from contracts with customers:
December 31,
20242023
Dx accounts receivable$1,259.3 $1,135.2 
BLS accounts receivable729.5 810.8 
Less BLS allowance for credit losses(44.7)(32.7)
Accounts receivable, net$1,944.1 $1,913.3 
Gross unbilled services$160.5 $192.9 
Less reserve for unbilled services(7.6)(7.5)
Unbilled services$152.9 $185.4 
Unearned revenue$392.2 $421.7 
Accounts Receivable, Allowance for Credit Loss
BLS estimates future expected losses on accounts receivable and unbilled services over the remaining collection period of the instrument. The rollforward for the allowance for credit losses is as follows:
Accounts ReceivableUnbilled ServicesTotal
Allowance for credit losses at December 31, 2022$30.8 $10.5 $41.3 
Credit loss expense6.3 — 6.3 
Write-offs(4.4)(3.0)(7.4)
Allowance for credit losses at December 31, 202332.7 7.5 40.2 
Credit loss expense14.6 0.1 14.7 
Write-offs(2.2)— (2.2)
Foreign currency impact(0.4)— (0.4)
Allowance for credit losses at December 31, 2024$44.7 $7.6 $52.3